null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Drug Discovery and Development, Third Edition

List Price: $67.99
SKU:
9781032084244
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    James J. O'Donnell, John Somberg, Vincent Idemyor, James T. O'Donnell
    Format:
    Paperback
    Pages:
    696
    Publisher:
    CRC Press (June 30, 2021)
    Language:
    English
    ISBN-13:
    9781032084244
    Weight:
    45.625oz
    Dimensions:
    7" x 10"
    File:
    TAYLORFRANCIS-TayFran_260403050944986-20260403.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $67.99
    As low as:
    $64.59
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Audience:
    Professional and scholarly
    Country of Origin:
    United States
    Pub Discount:
    30
    Imprint:
    CRC Press
    Case Pack:
    1
  • Overview

    Drug Discovery and Development, Third Edition presents up-to-date scientific information for maximizing the ability of a multidisciplinary research team to discover and bring new drugs to the marketplace. It explores many scientific advances in new drug discovery and development for areas such as screening technologies, biotechnology approaches, and evaluation of efficacy and safety of drug candidates through preclinical testing. This book also greatly expands the focus on the clinical pharmacology, regulatory, and business aspects of bringing new drugs to the market and offers coverage of essential topics for companies involved in drug development. Historical perspectives and predicted trends are also provided.



    Features:







    • Highlights emerging scientific fields relevant to drug discovery such as the microbiome, nanotechnology, and cancer immunotherapy; and novel research tools such as CRISPR and DNA-encoded libraries






    • Case study detailing the discovery of the anti-cancer drug, lorlatinib






    • Venture capitalist commentary on trends and best practices in drug discovery and development






    • Comprehensive review of regulations and their impact on drug development, highlighting special populations, orphan drugs, and pharmaceutical compounding






    • Multidiscipline functioning of an Academic Research Enterprise, plus a chapter on Ethical Concerns in Research


    • Contributions by 70+ experts from industry and academia specialists who developed and are practitioners of the science and business


    •